These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6636196)

  • 1. Effects of xylene exposure on the metabolism of antipyrine in vitro and in vivo in the rat.
    Toftgård R
    Toxicology; 1983 Sep; 28(1-2):117-31. PubMed ID: 6636196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of antipyrine and m-xylene in rats after prolonged pretreatment with xylene alone or xylene with ethanol, phenobarbital or 3-methylcholanthrene.
    Elovaara E; Engström K; Häyri L; Hase T; Aitio A
    Xenobiotica; 1989 Sep; 19(9):945-60. PubMed ID: 2815836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene.
    Lehman-McKeeman LD; Johnson DR; Caudill D
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):169-77. PubMed ID: 9007046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xylene induces a cytochrome P-450 isozyme in rat liver similar to the major isozyme induced by phenobarbital.
    Toftgård R; Halpert J; Gustafsson JA
    Mol Pharmacol; 1983 Jan; 23(1):265-71. PubMed ID: 6865901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition.
    Loft S; Poulsen HE
    Biochem Pharmacol; 1989 Apr; 38(7):1125-36. PubMed ID: 2706012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cytochrome P-450 in the rat liver after exposure to xylenes, dose-response relationship and dependence on endocrine factors.
    Toftgård R; Nilsen OG; Glaumann H; Gustafsson JA
    Toxicology; 1983 Jun; 27(2):119-37. PubMed ID: 6612743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musk xylene is a novel specific inducer of cytochrome P-450IA2.
    Iwata N; Minegishi K; Suzuki K; Ohno Y; Kawanishi T; Takahashi A
    Biochem Biophys Res Commun; 1992 Apr; 184(1):149-53. PubMed ID: 1567420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL; Chang T; Jaffe JM
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of xylene and xylene isomers on cytochrome P-450 and in vitro enzymatic activities in rat liver, kidney and lung.
    Toftgård R; Nilsen OG
    Toxicology; 1982; 23(2-3):197-212. PubMed ID: 7112593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
    Kahn GC; Boobis AR; Murray S; Davies DS
    Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the metabolism of aminopyrine, antipyrine and theophylline using monoclonal antibodies to cytochrome P-450 isozymes purified from rat liver.
    Slusher LB; Park SS; Gelboin HV; Vesell ES
    Biochem Pharmacol; 1987 Jul; 36(14):2359-67. PubMed ID: 2440440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug metabolizing capacity in vitro and in vivo--II. Correlations between hepatic microsomal monooxygenase markers in phenobarbital-induced rats.
    Matthew DE; Houston JB
    Biochem Pharmacol; 1990 Aug; 40(4):751-8. PubMed ID: 2386544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between antipyrine clearance and cytochrome P-450 level after phenobarbital induction in rat.
    Chang SL; Nelson SD; Levy RH
    Drug Metab Dispos; 1984; 12(1):139-41. PubMed ID: 6141905
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytochrome P450 isozyme induction by methyl ethyl ketone and m-xylene in rat liver.
    Raunio H; Liira J; Elovaara E; Riihimäki V; Pelkonen O
    Toxicol Appl Pharmacol; 1990 Mar; 103(1):175-9. PubMed ID: 2315928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acetone on the capacity of o-xylene and toluene to induce several forms of cytochrome P450 in rat liver.
    Nedelcheva V
    Cent Eur J Public Health; 1996 May; 4(2):119-22. PubMed ID: 8996725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
    Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.